---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-076515"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T17:50:25.310860+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pasithea completes tender offer: buys 5.32M shares at $0.70; post-offer shares 20.8M

## Summary
- All 5,323,451 validly tendered shares accepted for purchase at $0.70 per share, no proration.
- Tender offer expired Sept 8, 2023; funded from cash on hand.
- Post-offer shares outstanding: 20,819,956; CEO notes >8.5M shares repurchased over past 9 months.
- CEO: low tender indicates shareholder confidence; buyback provides liquidity and increases remaining holders' ownership.

## SEC filing metadata
- accession: 0001213900-23-076515
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390023076515/0001213900-23-076515-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390023076515/ea185161-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-076515
- JSON: https://secwatch.observer/filing/0001213900-23-076515.json
- Plain text: https://secwatch.observer/filing/0001213900-23-076515.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.